Differential protein kinase C phosphorylation sites in the L17 ribosomal protein from Leishmania infantum

G Gonzalez-Aseguinolaza1, S Taladriz, A Marquet

  • 1Centro de Investigaciones Biológicas, CSIC, Madrid, Spain.

Parasitology Research
|February 11, 2000
PubMed

Insights

Researchers cloned the L17 ribosomal protein gene from Leishmania infantum, a parasite causing leishmaniasis. This study reveals structural and expression differences, offering insights into parasite cell differentiation and potential therapeutic targets.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Cell Biology

Background:

  • Leishmania infantum causes leishmaniasis in Europe and exhibits developmental changes in vitro.
  • The parasite serves as a model for studying cell differentiation.
  • Ribosomal proteins play crucial roles in protein synthesis and cellular processes.

Purpose of the Study:

  • To clone and characterize the gene encoding the L17 ribosomal protein in Leishmania infantum.
  • To investigate the structural and functional properties of the LiL17 protein.
  • To explore the gene structure and expression patterns of LiL17 during parasite development.

Main Methods:

  • Gene cloning techniques were employed to isolate the L17 ribosomal protein gene.
  • Bioinformatic analysis was used to compare the LiL17 protein structure with related proteins.
  • Gene-structural analysis and expression studies were conducted to understand gene organization and regulation.

Main Results:

  • The LiL17 protein family is associated with the macrolide binding site and peptidyl transferase center of the ribosome.
  • Structural comparisons revealed variations in LiL17 compared to other family members, suggesting functional divergence.
  • Protein kinase C phosphorylation sites showed intermediate patterns.
  • Gene-structural analysis indicated the presence of two distinct encoding genes.
  • Differential gene expression was observed across different growth phases of the parasite.

Conclusions:

  • The L17 ribosomal protein in Leishmania infantum exhibits unique structural features and phosphorylation patterns.
  • The existence of multiple genes and differential expression suggests complex regulation of LiL17.
  • These findings contribute to understanding cell differentiation in Leishmania infantum and may offer targets for leishmaniasis treatment.

Related Concept Videos

Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...